Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2A6 | P11509 | 12/20 | 0.52 |
| ▸ | CYP3A4 | P08684 | 4/20 | 0.52 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.52 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.52 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.45 |
| ▸ | LMNA | P02545 | 1/20 | 0.45 |
| ▸ | TP53 | P04637 | 1/20 | 0.45 |
| ▸ | MAPT | P10636 | 1/20 | 0.45 |
| ▸ | HPGD | P15428 | 1/20 | 0.45 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.45 |
| ▸ | HTT | P42858 | 1/20 | 0.45 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.45 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.45 |
| ▸ | CYP2A13 | Q16696 | 1/20 | 0.41 |
| ▸ | CYP2B6 | P20813 | 4/20 | 0.40 |
| ▸ | CYP2E1 | P05181 | 3/20 | 0.40 |
| ▸ | CYP2C9 | P11712 | 3/20 | 0.40 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.39 |
| ▸ | MKNK1 | Q9BUB5 | 2/20 | 0.39 |
| ▸ | MKNK2 | Q9HBH9 | 2/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7240131 | 0.89 | AXL (0.42) | CYP2A6CYP3A4ALDH1A1CYP1A2KDM4E | |
| SCHEMBL20240638 | 0.82 | ALDH1A1 (0.35) | CYP2A6CYP3A4ALDH1A1CYP1A2KDM4E | |
| Hydrochloric Acid SCHEMBL8203837 | 0.81 | CYP2A6 (0.62) | CYP2A6ALDH1A1KDM4EMAPTHPGD | |
| SCHEMBL7239834 | 0.80 | NPC1 (0.52) | ALDH1A1CYP1A2KDM4EMAPTHPGD | |
| SCHEMBL14080751 | 0.77 | NOTUM (0.52) | ALDH1A1KDM4ELMNATP53MAPT | |
| SCHEMBL27838898 | 0.77 | NOTUM (0.52) | ALDH1A1KDM4ELMNATP53MAPT | |
| SCHEMBL2517442 | 0.75 | ALDH1A1 (0.35) | ALDH1A1KDM4ELMNAHPGDALOX15 | |
| SCHEMBL14562749 | 0.75 | ALDH1A1 (0.35) | ALDH1A1KDM4ELMNAHPGDALOX15 | |
| SCHEMBL7996476 | 0.75 | ALDH1A1 (0.35) | ALDH1A1KDM4ELMNAHPGDALOX15 | |
| SCHEMBL27979361 | 0.75 | ALDH1A1 (0.35) | ALDH1A1KDM4ELMNAHPGDALOX15 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 76 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0606453-B1 | PHOTOVOLTAIC CELL | ASULAB SA (CH) | 1997-06-04 | — | — | EP | claimed |
| US-5482570-A | Photovoltaic cell | ASULAB S.A. (CH) | 1996-01-09 | — | — | US | claimed |
| US-12546743-B2 | Electrochemical sensor and related methods | UNIVERSITY OF SOUTH FLORIDA (US) | 2026-02-10 | — | — | US | disclosed |
| EP-3183250-B1 | PROCESS FOR PREPARING CRYSTALLINE ORGANIC SEMICONDUCTOR MATERIAL | CLAP CO LTD (KR) | 2023-10-04 | — | — | EP | disclosed |
| US-20230296554-A1 | ELECTROCHEMICAL SENSOR AND RELATED METHODS | UNIVERSITY OF SOUTH FLORIDA | 2023-09-21 | — | — | US | disclosed |
| EP-3183757-B1 | ORGANIC SEMICONDUCTOR COMPOSITION COMPRISING LIQUID MEDIUM | CLAP CO LTD (KR) | 2022-05-04 | — | — | EP | disclosed |
| US-10454037-B2 | Organic semiconductor composition comprising a liquid medium | BASF SE (DE) | 2019-10-22 | — | — | US | disclosed |
| US-10224485-B2 | Process for preparing a crystalline organic semiconductor material | BASF SE (DE) | 2019-03-05 | — | — | US | disclosed |
| US-20170250347-A1 | ORGANIC SEMICONDUCTOR COMPOSITION COMPRISING A LIQUID MEDIUM | BASF SE (DE) | 2017-08-31 | — | — | US | disclosed |
| US-20170237005-A1 | PROCESS FOR PREPARING A CRYSTALLINE ORGANIC SEMICONDUCTOR MATERIAL | BASF SE (DE) | 2017-08-17 | — | — | US | disclosed |
| EP-3183757-A1 | ORGANIC SEMICONDUCTOR COMPOSITION COMPRISING LIQUID MEDIUM | BASF SE (DE) | 2017-06-28 | — | — | EP | disclosed |
| EP-2008319-A2 | LIQUID CRYSTALLINE RYLENE TETRACARBOXYLIC ACID DERIVATIVES AND USE THEREOF | BASF SE (DE) | 2008-12-31 | — | — | EP | disclosed |
| WO-2009000831-A1 | BROMINE-SUBSTITUTED RYLENE TETRACARBOXYLIC ACID DERIVATIVES, AND THE USE THEREOF | BASF SE (DE) | 2008-12-31 | — | — | WO | disclosed |
| WO-2009000756-A1 | USE OF N,N'-BIS(1,1-DIHYDROPERFLUORO-C3-C5-ALKYL)PERYLENE-3,4:9,10-TETRACARBOXYLIC DIIMIDES | BASF SE (DE) | 2008-12-31 | — | — | WO | disclosed |
| EP-1987092-A1 | FLUORINATED RYLENETETRACARBOXYLIC ACID DERIVATIVES AND USE THEREOF | BASF SE (DE) | 2008-11-05 | — | — | EP | disclosed |
| WO-2008113753-A1 | METHOD FOR THE PRODUCTION OF RYLENE TETRACARBOXYLIC ACID DIIMIDES THE IMIDE NITROGENS OF WHICH CARRY HYDROGEN ATOMS AND THE USE THEREOF | BASF SE (DE) | 2008-09-25 | — | — | WO | disclosed |
| WO-2007138051-A1 | DIBENZORYLENETETRACARBOXIMIDES AS INFRARED ABSORBERS | BASF SE (DE) | 2007-12-06 | — | — | WO | disclosed |
| WO-2007116001-A2 | LIQUID CRYSTALLINE RYLENE TETRACARBOXYLIC ACID DERIVATIVES AND USE THEREOF | BASF SE (DE) | 2007-10-18 | — | — | WO | disclosed |
| WO-2007093643-A1 | FLUORINATED RYLENETETRACARBOXYLIC ACID DERIVATIVES AND USE THEREOF | BASF SE (DE) | 2007-08-23 | — | — | WO | disclosed |
| US-6730666-B1 | INHIBITION OF GROWTH FACTOR TYROSINE KINASE RECEPTOR ACTIVITY, PARTICULARLY INHIBITION OF ANGIOGENESIS AND RELATED DISORDERS, TUMOR PROGRESSION AND GROWTH FACTOR RELATED SKELETAL DISORDERS, BY PORPHYRIN AND CORROLE COMPOUNDS | YEDA RESEARCH AND DEVELOPMENT CO. LTD. (IL) | 2004-05-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12546743-B2 | Electrochemical sensor and related methods | EPX, MUC1, EPCAM | CYP2A6 3617/4885CYP3A4 1275/4885ALDH1A1 1683/4885 |
| US-20170250347-A1 | ORGANIC SEMICONDUCTOR COMPOSITION COMPRISING A LIQUID MEDIUM | CRY1, NEFM, OR10J3 | CYP2A6 4140/4885CYP3A4 3807/4885ALDH1A1 4298/4885 |
| US-10454037-B2 | Organic semiconductor composition comprising a liquid medium | CRY1, NEFM, OR10J3 | CYP2A6 4140/4885CYP3A4 3807/4885ALDH1A1 4298/4885 |
| US-10224485-B2 | Process for preparing a crystalline organic semiconductor material | STOM, SPOP, TTR | CYP2A6 2194/4885CYP3A4 447/4885ALDH1A1 4757/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.